Heplisav-B vs Standard Hepatitis B Vaccine Booster for Health Care Workers
The Annals of Family Medicine · 2025
DOI: 10.1370/afm.240184 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Annals of Family Medicine, 2025. Verfasst von Alan L Williams und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Uniformed Services University, Bethesda, Maryland alan.williams@usuhs.edu. Hauptthemen laut MEDLINE: Hepatitis B Vaccines, Health Personnel, Hepatitis B, Immunization, Secondary. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Confidence in hepatitis B seroprotection for US health care workers includes a complete immunization series followed by a hepatitis B surface antigen antibody (anti-HBs) titer ≥10 mIU/mL. We compared standard hepatitis B vaccines to Heplisav-B (Dynavax Technologies Corp) as a single booster for young, healthy, previously vaccinated individuals. Participants (N = 242) had documentation of a single vaccination series and an anti-HBs titer
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Family Medicine, Uniformed Services University, Bethesda, Maryland alan.williams@usuhs.edu.
- Spangdahlem Air Base, 54529 Spangdahlem, AE, Germany.
Zitieren
APA
Williams, A. L., & Newman, R. S. (2025). Heplisav-B vs Standard Hepatitis B Vaccine Booster for Health Care Workers. The Annals of Family Medicine. https://doi.org/10.1370/afm.240184
Vancouver
Williams AL, Newman RS. Heplisav-B vs Standard Hepatitis B Vaccine Booster for Health Care Workers. The Annals of Family Medicine. 2025. doi:10.1370/afm.240184
BibTeX
@article{Williams2025,
author = {Williams, Alan L and Newman, Raquelle S},
title = {Heplisav-B vs Standard Hepatitis B Vaccine Booster for Health Care Workers},
journal = {The Annals of Family Medicine},
year = {2025},
doi = {10.1370/afm.240184}
}
EUVIMED